| MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN (NCT05495893) | Second Xiangya Hospital of Central South University | 2022-07-25 |
| Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis (NCT05126277) | Novartis Pharmaceuticals | 2022-07-14 |
| Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis (NCT05432531) | Assiut University | 2022-06-01 |
| VIBRANT: VIB4920 for Active Lupus Nephritis (NCT05201469) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-16 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants (NCT05039619) | Hoffmann-La Roche | 2022-05-12 |
| A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US (NCT05337124) | Aurinia Pharmaceuticals Inc. | 2022-04-05 |
| Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis (NCT05207358) | Institutul Clinic Fundeni | 2022-03-02 |
| Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis (NCT05138133) | AstraZeneca | 2022-02-15 |
| Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (NCT05097989) | Alexion Pharmaceuticals, Inc. | 2022-01-14 |
| Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis (NCT04449991) | Karolinska Institutet | 2022-01-05 |
| Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF (NCT04702256) | Assistance Publique - Hôpitaux de Paris | 2021-12-09 |
| Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital (NCT05120882) | Assiut University | 2021-12-01 |
| Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis (NCT07044115) | Beijing Mabworks Biotech Co., Ltd. | 2021-11-26 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis (NCT05085418) | Zhejiang University | 2021-11-05 |
| The Expression Profile of New Complement Components in Childhood Lupus Nephritis (NCT05082363) | Assiut University | 2021-11-01 |
| Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy (NCT05358652) | Fundacin Biomedica Galicia Sur | 2021-10-15 |
| Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis (NCT04892212) | Peking Union Medical College Hospital | 2021-06-30 |
| A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis (NCT04924296) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-06-28 |
| Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis (NCT05845151) | Ruijin Hospital | 2021-05-01 |
| Daratumumab to Treat Active Lupus Nephritis (NCT04868838) | Mayo Clinic | 2021-04-20 |
| Comparison between2 Drugs in Lupus Nephritis (NCT04424602) | Al-Azhar University | 2021-04-05 |
| Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis (NCT04645589) | Novartis Pharmaceuticals | 2021-03-16 |
| Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (NCT04564339) | Alexion Pharmaceuticals, Inc. | 2021-01-19 |
| Zanubrutinib in Participants With Active Proliferative Lupus Nephritis (NCT04643470) | BeiGene | 2020-12-22 |
| Epigenetics in Lupus Nephritis (NCT04648059) | University of Göttingen | 2020-12-01 |
| A Study of Guselkumab in Participants With Active Lupus Nephritis (NCT04376827) | Janssen Research & Development, LLC | 2020-09-15 |
| Pentoxifylline in Lupus Nephritis (NCT03859570) | MetroHealth Medical Center | 2020-09-01 |
| A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis (NCT04221477) | Hoffmann-La Roche | 2020-08-10 |
| Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis (NCT04181762) | Novartis Pharmaceuticals | 2020-07-07 |
| TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis (NCT04218890) | Assiut University | 2020-04-01 |
| Metformin In Prevention of Lupus Nephritis (NCT04145687) | RenJi Hospital | 2019-11-01 |
| Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis (NCT04128579) | Biocon Limited | 2019-10-01 |
| Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin (NCT03597464) | Aurinia Pharmaceuticals Inc. | 2019-09-29 |
| Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis (NCT03920059) | Chulalongkorn University | 2019-08-20 |
| Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis (NCT03958851) | Assiut University | 2019-08-01 |
| Urinary T Cell Biomarker for Prediction in Lupus Nephritis (NCT04320797) | Charite University, Berlin, Germany | 2019-07-30 |
| An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis (NCT03943147) | Bristol-Myers Squibb | 2019-07-15 |
| Identifying New Therapeutic Targets for Lupus Treatment (NCT03921398) | Assistance Publique - Hôpitaux de Paris | 2019-06-18 |
| Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort (NCT04534647) | Liga Panamericana de Asociaciones de Reumatologia (PANLAR) | 2019-06-01 |
| KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis (NCT03929887) | Seoul National University Hospital | 2019-05-01 |
| Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis (NCT03214731) | Sun Yat-sen University | 2019-01-16 |
| Multicenter Registry of Pediatric Lupus Nephritis in China (NCT03791827) | Xiqiang Dang | 2018-12-01 |
| Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. (NCT03610516) | Novartis Pharmaceuticals | 2018-09-12 |
| Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)? (NCT03664908) | CHU de Reims | 2018-09-01 |
| Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN) (NCT03580291) | Lingyun Sun | 2018-08-01 |
| Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis (NCT04146220) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2018-07-16 |
| A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt (NCT05195086) | Nada Magdy Mansour | 2018-07-01 |
| Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques (NCT03687138) | Natalia A. Rivera García | 2018-06-15 |
| Dynamic Imaging of Variation in Lupus Nephritis (NCT03180021) | RILITE Foundation | 2018-03-13 |
| Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies (NCT03453619) | Apellis Pharmaceuticals, Inc. | 2018-02-26 |
| A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (NCT03393013) | Kezar Life Sciences, Inc. | 2018-02-20 |
| Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis (NCT04522505) | Corestemchemon, Inc. | 2017-11-29 |
| Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis (NCT03526042) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2017-09-10 |
| The Iguratimod Effect on Lupus Nephritis (IGeLU) (NCT02936375) | RenJi Hospital | 2017-09-07 |
| Aurinia Renal Response in Active Lupus With Voclosporin (NCT03021499) | Aurinia Pharmaceuticals Inc. | 2017-05-17 |
| Detection of Annexin A2 in Systemic Lupus Erythematosus (NCT03031925) | Centre Hospitalier Universitaire, Amiens | 2017-05-09 |
| Iguratimod as Treatment for Refractory Lupus Nephritis (NCT03054545) | RenJi Hospital | 2017-05-08 |
| The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis (NCT02954939) | The University of Hong Kong | 2017-03-01 |
| Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis (NCT03458156) | The First Affiliated Hospital of Dalian Medical University | 2017-01-01 |
| Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis (NCT02770170) | Boehringer Ingelheim | 2016-05-16 |
| Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation (NCT04870359) | The University of Hong Kong | 2016-04-21 |
| Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis (NCT02630628) | The University of Hong Kong | 2015-12-05 |
| Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis (NCT02645565) | Jawaharlal Institute of Postgraduate Medical Education & Research | 2015-12-01 |
| Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis (NCT02547922) | AstraZeneca | 2015-11-04 |
| Rituximab and Belimumab for Lupus Nephritis (NCT02260934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-09 |
| Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis (NCT02949349) | Genovate Biotechnology Co., Ltd., | 2015-07-01 |
| Aurinia Early Urinary Protein Reduction Predicts Response (NCT02949973) | Aurinia Pharmaceuticals Inc. | 2015-06-01 |
| The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear (NCT02435368) | The Third Affiliated Hospital of Southern Medical University | 2015-04-01 |
| A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis (NCT02457221) | Astellas Pharma China, Inc. | 2015-03-10 |
| RING - Rituximab for Lupus Nephritis With Remission as a Goal (NCT01673295) | Frédéric A. Houssiau, MD, PhD | 2014-11-01 |
| ACTHar in the Treatment of Lupus Nephritis (NCT02226341) | Columbia University | 2014-10-01 |
| Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus (NCT05443516) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2014-06-16 |
| Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN) (NCT02176486) | Takeda | 2014-06-09 |
| AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) (NCT02141672) | Aurinia Pharmaceuticals Inc. | 2014-06-01 |
| Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla) (NCT02313974) | Hospital de Clinicas José de San Martín | 2014-01-01 |
| Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis (NCT04318600) | Yan'an Affiliated Hospital of Kunming Medical University | 2014-01-01 |
| High Quality Evidence of Chinese Lupus Nephritis (HELP) (NCT03001973) | Sun Yat-sen University | 2013-11-01 |
| BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis (NCT01930890) | Biogen | 2013-11-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Functional MRI in Lupus Nephritis (NCT01731054) | Biogen | 2013-06-01 |
| The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients (NCT02493101) | Chulalongkorn University | 2013-04-01 |
| Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) (NCT01802034) | The Rogosin Institute | 2013-02-01 |
| Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis (NCT01714817) | Bristol-Myers Squibb | 2013-01-22 |
| Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy (NCT01765842) | Fundación Pública Andaluza Progreso y Salud | 2012-11-01 |
| Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis (NCT02453997) | The University of Hong Kong | 2012-10-01 |
| Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis (NCT01639339) | Human Genome Sciences Inc., a GSK Company | 2012-07-12 |
| BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (NCT01499355) | Biogen | 2012-07-01 |
| Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis (NCT01580865) | Ramathibodi Hospital | 2012-05-01 |
| Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients (NCT04266860) | Qure Healthcare, LLC | 2012-03-01 |
| Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis (NCT01539902) | CytoMed & Beike | 2012-02-01 |
| Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients (NCT01470183) | Columbia University | 2011-10-01 |
| An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis (NCT01273389) | Janssen Research & Development, LLC | 2011-08-01 |
| Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis (NCT03828071) | Nanjing University School of Medicine | 2011-06-01 |
| Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil (NCT01369628) | EMD Serono | 2011-06-01 |
| A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients (NCT01316133) | Astellas Pharma Korea, Inc. | 2011-04-19 |
| A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients (NCT01342016) | Astellas Pharma Inc | 2011-04-01 |
| Clinical Trial Treatment in Lupus Nephritis (NCT01299922) | Hospital Universitario Fundación Alcorcón | 2011-02-01 |
| Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis (NCT01288664) | Sun Yat-sen University | 2011-01-01 |
| Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis (NCT01226147) | Kinki University | 2010-09-01 |
| Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis (NCT01206569) | Chinese University of Hong Kong | 2010-09-01 |